The hidden truth about medical research isn't the drug, it's the math. Unmasking the biostatisticians driving clinical trial outcomes.
Pennsylvania's lagging tobacco control is a political failure. Unpacking the real losers in the vaping and cigarette wars.
The FDA is granting manufacturing flexibility for cell and gene therapies. But the real story isn't access; it’s who benefits from this regulatory shift in biopharma.
The mass departure of key FDA digital health leaders signals a regulatory vacuum. Discover the hidden power shift in digital health innovation.
The FDA's new digital health services pilot, lauded by the AHA, signals a massive shift in medical liability. Discover who really benefits from this regulatory experiment.